FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

68816011000036104: Mylanta Double Strength reformulation (aluminium hydroxide 400 mg / 5 mL + magnesium hydroxide 400 mg / 5 mL + simethicone 30 mg / 5 mL) oral liquid, 200 mL, bottle (containered trade product pack)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2733321000168119 Mylanta Double Strength reformulation oral liquid, 200 mL, bottle en Synonym Active Case sensitive Australian Medicines Terminology module
2736281000168116 Mylanta Double Strength reformulation (aluminium hydroxide 400 mg / 5 mL + magnesium hydroxide 400 mg / 5 mL + simethicone 30 mg / 5 mL) oral liquid, 200 mL, bottle (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mylanta Double Strength reformulation oral liquid, 200 mL, bottle Is a containered trade product pack true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 200 mL, bottle Is a Mylanta Double Strength reformulation oral liquid, 200 mL true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 200 mL, bottle has container type bottle true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 200 mL, bottle has TPUU Mylanta Double Strength reformulation oral liquid, 5 mL true Inferred relationship Some 1
Mylanta Double Strength reformulation oral liquid, 200 mL, bottle has TP Mylanta Double Strength true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start